Clinical Trial Update: Autologous Transplantation of Mesenchymal Stem Cells for Treatment of Patients With Onset of Type 1 Diabetes [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial update exploring autologous mesenchymal stem cell transplantation for onset of Type 1 diabetes, with status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Autologous mesenchymal stem cell transplantation (Mesenchymal stem cells)

Snippet

Sponsor: Lu Debin | Conditions: Evidence of Liver Transplantation | Phase 2, Phase 3 | Status: UNKNOWN